Literature DB >> 22226013

[Relationship between precariousness, social coverage, and vaccine coverage: survey among children consulting in pediatric emergency departments in France].

N Bouhamam1, R Laporte, A Boutin, M Uters, V Bremond, G Noel, P Rodier, P Minodier.   

Abstract

UNLABELLED: Poor children are more susceptible to infectious diseases. Routine medical follow-up is infrequent in these patients, sometimes resulting in immunization delays. The aim of this study was to correlate a number of socioeconomic factors related to poverty with vaccination coverage in children visiting a pediatric emergency ward. PATIENTS AND METHODS: Previous routine vaccinations and various socioeconomic features were prospectively recorded for children aged 9 months to 7 years visiting two public pediatric emergency departments in Marseilles (southern France) from 2009 to 2010.
RESULTS: Three hundred and seventy-five children were included. Vaccination coverage was 87% for diphtheria, tetanus, poliomyelitis, Haemophilus influenzae type b infections and pertussis, 69% for tuberculosis (Bacillus Calmette-Guérin), 77% for measles, mumps and rubella, 74% for pneumococcal infections (conjugate vaccine), and 55% for hepatitis B. Socioeconomic factors related to poverty were significantly associated with delays in immunizations. Children not attending school (OR=2.5), having parents who were not fluent in French (OR=5.7), living in caravans or squatting (OR=11.5), or being recipients of the national medical assistance for foreigners (OR=12.8) had significant delays with diphtheria, tetanus, and poliomyelitis vaccines. The measles-mumps-rubella vaccine was also delayed in homeless children (OR=3.4). Children who were recipients of the national medical assistance for citizens were better vaccinated against tuberculosis and hepatitis B.
CONCLUSION: Poor children living in southern France had significant delays in their routine immunizations, resulting in gaps in their protection. Every medical visit, even those conducted in an emergency ward, should identify children with immunization delays and offer a catch-up schedule if necessary. Copyright Â
© 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22226013     DOI: 10.1016/j.arcped.2011.12.001

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  4 in total

Review 1.  Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.

Authors:  Alison F Crawshaw; Yasmin Farah; Anna Deal; Kieran Rustage; Sally E Hayward; Jessica Carter; Felicity Knights; Lucy P Goldsmith; Ines Campos-Matos; Fatima Wurie; Azeem Majeed; Helen Bedford; Alice S Forster; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2022-04-13       Impact factor: 71.421

Review 2.  Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis.

Authors:  Garden Tabacchi; Claudio Costantino; Giuseppe Napoli; Valentina Marchese; Manuela Cracchiolo; Alessandra Casuccio; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2016-05-10       Impact factor: 3.452

3.  Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey.

Authors:  Samreen Mansor-Lefebvre; Yann Le Strat; Anne Bernadou; Nicolas Vignier; Jean-Paul Guthmann; Amandine Arnaud; Daniel Lévy-Bruhl; Stéphanie Vandentorren
Journal:  Int J Environ Res Public Health       Date:  2020-04-21       Impact factor: 3.390

Review 4.  Measles among migrants in the European Union and the European Economic Area.

Authors:  Gemma A Williams; Sabrina Bacci; Rebecca Shadwick; Taavi Tillmann; Bernd Rechel; Teymur Noori; Jonathan E Suk; Anna Odone; Jonathan D Ingleby; Philipa Mladovsky; Martin Mckee
Journal:  Scand J Public Health       Date:  2015-11-12       Impact factor: 3.021

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.